TAF1-dependent transcriptional dysregulation underlies multiple sclerosis
Claudia Rodríguez-López, Ivó H. Hernández, José Terrón-Bautista…·José J. Lucas
This study identifies TAF1-dependent transcriptional dysregulation as a mechanism underlying multiple sclerosis progression and presents an in vivo model for therapeutic development.